AxoGen, Inc. to Report Fourth Quarter and Full Year Financial Results on March 5, 2015

Share Article

AXGN Investor Conference Call and Webcast Scheduled for Friday, March 6, 2015 at 8:30am ET

AxoGen Logo

AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the peripheral nerve repair market, will report results for the fourth quarter and full year ended December 31, 2014 on Thursday, March 5, 2015 following the close of the market.

The Company will host a conference call and webcast for the investment community on Friday, March 6, 2015 at 8:30 AM ET. Investors interested in participating by phone are invited to call toll free at 1.877.407.0993 or use the direct dial-in number 1.201.689.8795. Those interested in joining via the webcast, should visit http://axogeninc.equisolvewebcast.com/q4-2014.

Following the conference call, a replay will be available on the Company’s website at http://www.AxoGenInc.com, under ‘Investors.’

About AxoGen, Inc.

AxoGen (NASDAQ: AXGN) is a leading medical technology company dedicated to peripheral nerve repair. AxoGen’s portfolio of regenerative medicine products is available in the United States, Canada and several other countries and includes Avance® Nerve Graft, an off-the-shelf commercially available processed nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site, AxoGuard® Nerve Connector, a porcine submucosa extracellular matrix (“ECM”) coaptation aid for tensionless repair of severed nerves, and AxoGuard® Nerve Protector, a porcine submucosa ECM product used to wrap and protect injured peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments.

Avance® Nerve Graft is processed in the United States by AxoGen. AxoGuard® Nerve Connector and AxoGuard® Nerve Protector are manufactured in the United States by Cook Biotech Incorporated, and are distributed worldwide exclusively by AxoGen. AxoGen maintains its corporate offices in Alachua, Florida and is the parent of its wholly owned operating subsidiary, AxoGen Corporation.

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Lee Robert "Bob" Johnston Jr, CFO
AxoGen, Inc.
+1 386.462.6856
Email >

Bob Jones / Michael Polyviou
EVC Group
646.201.5447
Email >
Visit website